Suchergebnisse - "Myeloma"

PubPharm (528)

1

Talquetamab - multiple myeloma after at least three prior lines of therapy

enthalten in: Bulletin du cancer | 2024

von Fatrara, T. | Chalayer, E.

2

Cardiac tamponade as first manifestation of multiple myeloma : A case report with literature review

enthalten in: Annales de cardiologie et d'angeiologie | 2023

von Loukhnati, M. | Lahlimi, F. | Tazi, I.

3

Teclistamab as monotherapy in patients with relapsed or refractory multiple myeloma who received three or more lines of therapy

enthalten in: Bulletin du cancer | 2023

von Le Grand, S. | Karlin, L.

4

Renal failure in multiple myeloma : Specific management issues

enthalten in: Bulletin du cancer | 2023

von Try, M. | Harel, S.

5

A novel cause of acute kidney injury in multiple myeloma : Lenalidomide-induced acute interstitial nephritis

enthalten in: Nephrologie & therapeutique | 2022

von Fofana, A. | Bouaka, C. | Alchahin, G. | +8

6

What a cardiologist needs to know about managing a patient with multiple myeloma

enthalten in: Annales de cardiologie et d'angeiologie | 2022

von Gilles, F.

7

Lower-back pain and weight loss in a 75-year-old man

enthalten in: Annales de biologie clinique | 2022

von Sarthou, A. | Bouchet-Seraphin, C. | Hurtado-Nedelec, M. | +1

8

New drug approval : Ciltacabtagene autoleucel - in patients with relapsed or refractory multiple myeloma who received 3 or more lines of therapy

enthalten in: Bulletin du cancer | 2022

von Chacon, A. | Bobin, A. | Leleu, X.

9

Nouveaux traitements du myélome multiple

enthalten in: La Revue du praticien | 2022

von Schavgoulidze, A. | Perrot, A.

10

New European approval : Idecabtagene vicleucel in relapsed and/or refractory myeloma after at least 3 lines of treatment

enthalten in: Bulletin du cancer | 2022

von Croizier, C. | Van de Wyngaert, Z.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[53]